Skip to Accessibility Tools Skip to Content Skip to Footer

Triumeq

Triumeq is a combination medication that contains abacavir, dolutegravir, and lamivudine. It can be used on its own or with other antiretroviral agents as a part of antiretroviral therapy (ART) for HIV-1 in adults and children who are at least 88 pounds (40 kg). Although it is not a cure for HIV, when taken as directed, it allows for the virus to be suppressed. This prevents further transmission of HIV and allows an individual’s immune system to improve through increasing CD4 cell counts and decreasing the amount of active virus in the blood (viral load).

What are the ingredients in Triumeq?

The main ingredients in Triumeq are abacavir, dolutegravir, and lamivudine. Abacavir and lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs), while dolutegravir is an integrase strand transfer inhibitor (INSTI, also known as an integrase inhibitor).

How does Triumeq work?

Triumeq is a combination of two NRTI medications and one integrase inhibitor. NRTIs stop the reverse transcription step of the HIV life cycle. Normally, HIV uses its reverse transcriptase enzyme to build a strand of DNA from its original RNA form. In order to do this, it uses genetic building blocks called nucleosides that come from the host cell. These nucleosides are strung together one at a time, like beads on a string, to create the final DNA product.

NRTIs act as nucleoside mimics that stop the DNA-building process. NRTIs look like normal nucleosides, except they’re missing a special chemical group on one side. Without this group, the reverse transcriptase enzyme is unable to attach more nucleosides to the chain after them. This prevents the full string of DNA from being formed, preventing HIV RNA from making it all the way through the reverse transcription process.

After HIV RNA is reverse transcribed into newly-formed DNA, it gets integrated into the host cell DNA using an enzyme called integrase. This allows HIV to be actively replicated with the rest of our DNA as our cell carries out its normal functions. Integrase inhibitors can be used to block the integrase enzyme and prevent the integration of HIV DNA into our host cells. If HIV’s DNA cannot be inserted into our host cells’ genome, the virus cannot continue to be replicated, assembled into mature virus particles, and released into the blood to continue infecting other cells.

What are the possible side effects of Triumeq?

The most common side effects of Triumeq include, but are not limited to:

  • Insomnia
  • Headache
  • Fatigue

Things to note about Triumeq

As with any medication, there are several very rare but serious risks that need to be considered before taking Triumeq. Your healthcare provider can help determine what issues you may be at risk for and help determine what treatment options are the safest for you. It’s also important to remember that the risk of one or more of these issues occurring is low, and the benefits of treating the virus often greatly outweigh the risks.

One of the ingredients in Triumeq, abacavir, can cause severe allergic reactions in certain individuals. Although this is very rare, it is especially true for individuals with a gene mutation called HLA-B*5701. A blood test can be used to determine if someone has this mutation before starting the medication. An individual may be having an allergic reaction if they have a symptom from two or more of the following categories:

  1. Fever
  2. Rash
  3. Abdominal pain, diarrhea, nausea, vomiting
  4. Extreme tiredness, achiness, or a feeling of generally being ill
  5. Sore throat, cough, shortness of breath

If you have, or think you may have, an allergic reaction to Triumeq, seek medical attention immediately and never restart Triumeq or another abacavir-containing product, as serious events including death may occur. If you stop Triumeq for any reason, tell your healthcare provider before starting the medication again.

Other rare but serious side effects of Triumeq include liver issues and an increase of lactic acid in the blood (lactic acidosis). Signs of liver issues include, but are not limited to:

  • Dark-colored urine
  • Loss of appetite
  • Nausea
  • Yellowing of the whites of the eyes or skin
  • Light-colored bowel movements
  • Pain or tenderness on the right side of your stomach

Signs of lactic acidosis include, but are not limited to:

  • Trouble breathing
  • Feeling cold, especially in the limbs
  • Dizziness or lightheadedness
  • Feeling tired or weak
  • Muscle pain
  • Nausea and vomiting
  • Irregular or fast heartbeat

Although rare, Triumeq may also increase an individual’s risk of having a heart attack. It is important to tell your healthcare provider if you have any heart issues or have had heart issues in the past. Also, if you have hepatitis B virus and start taking Triumeq, your hepatitis B may get worse. Individuals taking a medication called dofetilide should not take Triumeq, as serious or life-threatening side effects may occur.

Before starting Triumeq, tell your doctor if you:

  • Have or previously had hepatitis B virus
  • Have or previously had hepatitis C virus
  • Have a history of liver, heart, or kidney problems
  • Have a history of high blood pressure, high cholesterol, or diabetes
  • Are a smoker
  • Drink alcohol or take medicine with alcohol in them
  • Are pregnant or planning to become pregnant
  • Are breastfeeding or planning to breastfeed
  • Are taking any over-the-counter vitamins, supplements, medicines, or herbal remedies
  • Are on any other medications or are about to start any other medications, including hormonal birth control or medications for hepatitis viruses

Triumeq may cause a condition called IRIS (immune reconstitution inflammatory syndrome). IRIS occurs when an individual’s immune system gets stronger after being weak and responds aggressively to previously hidden infections. This heightened response may make the person fighting the infection feel worse. Alert your healthcare provider immediately if you begin to have new symptoms after taking Triumeq.

Dosing information

The most common dosage of Triumeq is one tablet taken by mouth each day. A tablet contains 600 mg of abacavir, 50 mg of dolutegravir, and 300 mg of lamivudine. An additional dosage of dolutegravir may be needed for individuals taking certain medications, including medications classified as UGT1A or CYP3A inducers.

It is important to take your medication exactly as prescribed and to not stop or change your Triumeq dosage without talking to your healthcare provider first. Triumeq can be taken with or without food. If you miss a dose of Triumeq, take the next dose as soon as you remember, however, never take two at a time. If you take too much Triumeq, seek medical attention immediately.

If you take antacids, laxatives, iron supplements, calcium supplements, or medicines that contain aluminum, or magnesium, your dosing schedule of Triumeq may need to be adjusted. Your healthcare provider will let you know what schedule you should be on based on other medications and supplements you take.1,2

Written by: Casey Hribar | Last reviewed: September 2019
  1. Triumeq. United States Department of Health and Human Services: AIDSinfo. https://aidsinfo.nih.gov/drugs/534/triumeq/0/patient. Published June 9, 2019. Accessed July 20, 2019.
  2. Triumeq Prescribing Information. GlaxoSmithKline. https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Triumeq/pdf/TRIUMEQ-PI-MG.PDF. Published March 2019. Accessed July 20, 2019.